Does RUXOLITINIB Cause Platelet count decreased? 3,028 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,028 reports of Platelet count decreased have been filed in association with RUXOLITINIB (OPZELURA). This represents 4.4% of all adverse event reports for RUXOLITINIB.
3,028
Reports of Platelet count decreased with RUXOLITINIB
4.4%
of all RUXOLITINIB reports
540
Deaths
1,198
Hospitalizations
How Dangerous Is Platelet count decreased From RUXOLITINIB?
Of the 3,028 reports, 540 (17.8%) resulted in death, 1,198 (39.6%) required hospitalization, and 162 (5.4%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 3,028 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
Headache (2,271)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
CARBOPLATIN (1,597)
Which RUXOLITINIB Alternatives Have Lower Platelet count decreased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE